Key points from article :
The Hevolution Global Healthspan Summit 2025 showcased the foundation’s rapid rise as a major player in longevity research. Led by CEO Dr. Mehmood Khan, Hevolution emphasized a shift from focusing solely on lifespan to prioritizing healthspan—the years lived in good health. The summit, now the world’s largest longevity conference, gathered over 3,000 attendees and highlighted Hevolution’s growing influence, with over $400 million invested in geroscience research and biotech.
Key discussions included expanding the Hallmarks of Aging framework, measuring resilience as a marker of ageing, and innovative bioelectricity-based approaches to regeneration. Dr. Felipe Sierra emphasized that ageing research should move beyond disease prevention to maintaining overall health and function. Dr. Elena Sergeeva presented groundbreaking work on bioelectricity’s role in guiding cell behaviour, potentially unlocking new regenerative therapies. Meanwhile, Dr. Alan Cohen proposed targeting "intrinsic health" rather than ageing itself, using biological markers to assess overall well-being.
The conference also highlighted advances in ageing biomarkers, with Harvard’s Dr. Vadim Gladyshev and Altos Labs’ Dr. Steve Horvath showcasing improved epigenetic clocks that predict ageing and disease risk. A panel on comparative biology explored how long-lived species like naked mole rats and hibernating animals could reveal secrets to longevity. As Hevolution continues to shape the field, its push for global collaboration and innovative approaches is redefining the future of healthy ageing research.
